Researchers use real-world data in the United States to evaluate the protective role of semaglutide against Alzherimer’s disease.
Semaglutide may reduce Alzheimer’s risk in diabetics
- Post author:
- Post published:October 25, 2024
- Post category:uncategorized
- Post comments:0 Comments